Manufacturing


AstraZeneca globally employs approximately 59,700 employees and manufactures in 15 countries.

 

AstraZeneca Australia is the largest national manufacturer of pharmaceuticals, providing over A$500 million of medicines to the local market and approximately A$496million in exports to 15 international markets including, China, Japan and New Zealand.

Our manufacturing plant based in North Ryde, Sydney, is a world-class facility dedicated to the production of high-quality medicines that make a difference to the lives of patients all around the world. We are one of the largest manufacturers of pharmaceuticals in Australia.


$500 million

of medicines provided to the local market

>80

different product variations of local anaesthetics, diluents and respiratory products are manufactured.


We are the global sole supplier to China of a primary respiratory product used in the treatment of Asthma. We are key partners for leadership and technical capability within the Asia Pacific operations network.

Our site has a proven track record of delivering outstanding supply performance and is regarded as one of the most cost-efficient and successful manufacturing sites in the AstraZeneca global network.